RECENT ADVANCES IN STRATEGIES FOR IMMUNOTHERAPY OF HUMAN PAPILLOMAVIRUS-INDUCED LESIONS

Por Kanodia, Shreya, Da Silva, Diane M., Kast, W. Martin
Publicado no Int J Cancer (2008)

Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines

Por Chiriva-Internati, Maurizio, Cobos, Everardo, Da Silva, Diane M., Kast, W. Martin
Publicado em 2008

Functional analysis of Human Papillomavirus Virus-Like Particle activated Langerhans cells in vitro

Por Yan, Lisa, Woodham, Andrew W., Da Silva, Diane M., Kast, W. Martin
Publicado no Methods Mol Biol (2015)

Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16

Por Fahey, Laura M., Raff, Adam B., Da Silva, Diane M., Kast, W. Martin
Publicado em 2009

A major role for the minor capsid protein of human papillomavirus type 16 in immune escape

Por Fahey, Laura M., Raff, Adam B., Da Silva, Diane M., Kast, W. Martin
Publicado em 2009

Molecular analysis of Human Papillomavirus Virus-Like Particle activated Langerhans cells in vitro

Por Woodham, Andrew W., Raff, Adam B., Da Silva, Diane M., Kast, W. Martin
Publicado no Methods Mol Biol (2015)

Expression of LIGHT/TNFSF14 Combined with Vaccination against Human Papillomavirus Type 16 E7 Induces Significant Tumor Regression

Por Kanodia, Shreya, Da Silva, Diane M., Karamanukyan, Tigran, Bogaert, Lies, Fu, Yang-Xin, Kast, W. Martin
Publicado em 2010

A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours

Por Bogaert, Lies, Woodham, Andrew W., Da Silva, Diane M., Martens, Ann, Meyer, Evelyne, Kast, W. Martin
Publicado no J Gen Virol (2015)

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

Por Skeate, Joseph G., Woodham, Andrew W., Einstein, Mark H., Da Silva, Diane M., Kast, W. Martin
Publicado no Hum Vaccin Immunother (2016)

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells

Por Da Silva, Diane M., Woodham, Andrew W., Naylor, Paul H., Egan, James E., Berinstein, Neil L., Kast, W. Martin
Publicado no J Interferon Cytokine Res (2016)

Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a μ genotype

Por Da Silva, Diane M., Movius, Carly A., Raff, Adam B., Brand, Heike E., Skeate, Joseph G., Wong, Michael K., Kast, W. Martin
Publicado em 2014

Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment

Por Woodham, Andrew W., Skeate, Joseph G., Sanna, Adriana M., Taylor, Julia R., Da Silva, Diane M., Cannon, Paula M., Kast, W. Martin
Publicado no AIDS Patient Care STDS (2016)

Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro

Por Woodham, Andrew W., Sanna, Adriana M., Taylor, Julia R., Skeate, Joseph G., Da Silva, Diane M., Dekker, Lodewijk V., Kast, W. Martin
Publicado no Virol J (2016)

The Evolving Field of Human Papillomavirus Receptor Research: a Review of Binding and Entry

Por Raff, Adam B., Woodham, Andrew W., Raff, Laura M., Skeate, Joseph G., Yan, Lisa, Da Silva, Diane M., Schelhaas, Mario, Kast, W. Martin
Publicado em 2013

Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes

Por Yan, Lisa, Da Silva, Diane M., Verma, Bhavna, Gray, Andrew, Brand, Heike E., Skeate, Joseph G., Porras, Tania B., Kanodia, Shreya, Kast, W. Martin
Publicado no Prostate (2014)

Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection

Por Woodham, Andrew W., Taylor, Julia R., Jimenez, Andrew I., Skeate, Joseph G., Schmidt, Thomas, Brand, Heike E., Da Silva, Diane M., Kast, W. Martin
Publicado no J Antimicrob Chemother (2015)

T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation

Por Woodham, Andrew W., Yan, Lisa, Skeate, Joseph G., van der Veen, Daniel, Brand, Heike E., Wong, Michael K., Da Silva, Diane M., Kast, W. Martin
Publicado no Papillomavirus Res (2016)

The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection

Por Woodham, Andrew W., Da Silva, Diane M., Skeate, Joseph G., Raff, Adam B., Ambroso, Mark R., Brand, Heike E., Isas, J. Mario, Langen, Ralf, Kast, W. Martin
Publicado em 2012

Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression()

Por Woodham, Andrew W., Raff, Adam B., Raff, Laura M., Da Silva, Diane M., Yan, Lisa, Skeate, Joseph G., Wong, Michael K., Lin, Yvonne G., Kast, W. Martin
Publicado em 2014

Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Malignant Melanoma: Southwest Oncology Group S0508

Por Clark, Joseph I., Moon, James, Hutchins, Laura F., Sosman, Jeffrey A., Kast, W. Martin, Da Silva, Diane M., Liu, P.Y., Thompson, John A., Flaherty, Lawrence E., Sondak, Vernon K.
Publicado em 2010